Search
Displaying 331–340 of 689 for “retinitis clinical trial”
-
VISIONS 2014 — My Retina Tracker: Track Your Vision and Drive the Research
Research NewsThe powerful and secure system enables patients to keep track of their clinical care and vision changes. At the same time, it enables scientists to search the “de-identified” (i.e., anonymous) patient information to study conditions and identify targets for treatments, preventions and cures.
-
The fiscal year 2025-2029 Science Strategic Plan is developed with a single, overarching goal: To drive research projects and activities to overcome barriers to translating preclinical research into clinical trials for individuals affected by inherited retinal diseases and dry AMD.
-
Penn Vet’s William Beltran Elected to the National Academy of Medicine
Research NewsThe veterinary researcher’s canine studies are advancing promising retinal therapies toward clinical trials
-
To Treat an Inherited Retinal Disease, It's Good to Know Exactly What's Wrong with the Gene
Research NewsIdentifying mutations cannot only help deliver a prognosis for a patient, it can direct them to clinical trials for therapies to save their vision.
-
Retinal Research Community Loses Beloved Pioneer Sam Jacobson
Beacon StoriesHis many contributions included pivotal work that led to LUXTURNA
-
Fighting RP on the Foundation’s Frontline
Beacon StoriesMichelle Glaze, the Foundation’s associate director of professional outreach, shared her personal story of being diagnosed with retinitis pigmentosa (RP) in the film ‘Decoding disease.‘ In her own words, Michelle also describes her journey with genetic testing and the Foundation Fighting Blindness’ impact on her life.
-
My Retina Tracker Program and Registry Featured in American Journal of Medical Genetics
Research NewsThe paper provides insights into the genetic landscape of inherited retinal diseases
-
Abfero Targeting Excess Iron to Treat AMD, Other Retinal Diseases
Partner NewsAn intriguing link between excess body iron and retinal degeneration is being explored by Abfero Pharmaceuticals, a young biotech based in Boston and Oxford, UK.
-
Research News
Eye Bonds provide the opportunity to advance, and accelerate development for, more promising treatments into and through clinical trials and out to the people who need them.
-
Recording Available for Achromatopsia Teleconference Hosted by AGTC, Foundation, and Achroma Corp
Research NewsApplied Genetic Technologies Corporation (AGTC), Achroma Corp, and the Foundation Fighting Blindness hosted a one-hour teleconference on the condition. The call highlighted the difficulties patients have in getting a diagnosis for achromatopsia, the importance of genetic testing, and gene therapy clinical trials underway.
